𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Long-term outcome of patients with lamivudine after early cessation of hepatitis B immunoglobulin for prevention of recurrent hepatitis B following liver transplantation

✍ Scribed by M. Yuefeng; F. Weili; T. Wenxiang; X. Ligang; L. Guiling; G. Hongwei; L. Wencai; W. Xiaoguang; M. Wei; F. Zhongyi


Book ID
110890411
Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
83 KB
Volume
25
Category
Article
ISSN
0902-0063

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Prevention of hepatitis B recurrence aft
✍ Shusen Zheng; Yaomin Chen; Tingbo Liang; Anwei Lu; Weilin Wang; Yan Shen; Min Zh πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 109 KB πŸ‘ 1 views

The aim of our study was to determine the outcomes of liver transplant recipients receiving either lamivudine (LAM) monotherapy or LAM combined with low-dose intramuscular (IM) hepatitis B Immunoglobulin (HBIG) therapy. We performed a retrospective review of the medical records of patients that had